Interestingly, like LILRB1/LILRB4, serum soluble HLA-G levels are much higher in AML M4/M5 subtypes compared to control serum and serum from AML M1/M2 patients [45]. This evidence concerns the gene HLA-G and acute myeloid leukemia.